Trial Profile
A Study to Evaluate the Effects of Rosuvastatin as an Adjuvant Treatment for Deep Vein Thrombosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Jun 2016
Price :
$35
*
At a glance
- Drugs Low molecular weight heparins (Primary) ; Rosuvastatin (Primary)
- Indications Deep vein thrombosis
- Focus Therapeutic Use
- 22 Jun 2016 New trial record